List

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for the given year is not complete until April of the following year. Annual Reports data is a snapshot of agency reported information for that year and hence might look different from the live data in the Awards Information charts.

Displaying 1 - 10 of 36304 results
  1. SBIR Phase II: OCT-Compatible Imaging Adaptor for Precision Vascular Access via Hollow-Bore Needles

    SBC: WEST FACE MEDICAL DEVICES, INC.            Topic: BM

    This SBIR Phase II project supports development of a commercially viable real time optical imaging device to address the problem of failed first time vascular access. Peripheral IV access (PIV) is the most common invasive procedure for all ages, races and clinical settings. In the United States alone, there are an estimated 230 million PIVs placed per year. First time IV access has a shockingly hi ...

    SBIR Phase II 2019 National Science Foundation
  2. SBIR Phase II: OCT-Compatible Imaging Adaptor for Precision Vascular Access via Hollow-Bore Needles

    SBC: WEST FACE MEDICAL DEVICES, INC.            Topic: BM

    This SBIR Phase II project supports development of a commercially viable real time optical imaging device to address the problem of failed first time vascular access. Peripheral IV access (PIV) is the most common invasive procedure for all ages, races and clinical settings. In the United States alone, there are an estimated 230 million PIVs placed per year. First time IV access has a shockingly hi ...

    SBIR Phase II 2019 National Science Foundation
  3. SBIR Phase II: Non-Invasive Retinal Oximetry for Detecting Diabetic Retinopathy prior to Structural Damage

    SBC: Bioxytech Retina            Topic: BM

    This SBIR Phase II project demonstrates and clinically validates a novel, non-invasive imaging technology to detect diabetic retinopathy before structural damage occurs. Diabetic retinopathy is among the leading causes of vision loss in the world. This devastating complication of both type I and II diabetes results in structural damage to the sensitive vasculature of the retina. Once structural da ...

    SBIR Phase II 2019 National Science Foundation
  4. SBIR Phase II: A platform for identifying antibodies that modulate human membrane receptors involved in disease

    SBC: Abalone Bio, Inc.            Topic: BT

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is to develop a drug discovery platform that will identify novel types of antibody therapeutics. The goal is to use antibodies to increase or decrease the activity of a type of cell signaling receptor called "G protein-coupled receptors" (GPCRs). There are more than 400 non-olfactory human GP ...

    SBIR Phase II 2019 National Science Foundation
  5. SBIR Phase I: A novel AR on LBO

    SBC: Gamdan Optics, Inc            Topic: PH

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is as diverse as the laser technology itself. Lasers have become the true facilitator of the data-based society. It is tool of choice for future smart factories and on-demand manufacturing. It serves as the fundamental building block of optical sensing systems used to collect large volumes of ...

    SBIR Phase I 2019 National Science Foundation
  6. SBIR Phase I: MedSwarm, an Artificial Intelligence System for Medical Decision Making

    SBC: Unanimous A.I., Inc.            Topic: DH

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to demonstrate the feasibility of MedSwarm, a software product for radiology that will significantly improve patient outcomes and reduce medical costs. MedSwarm is an AI-based collaborative decision-making system that will significantly amplify diagnostic accuracy across a wide range diagno ...

    SBIR Phase I 2019 National Science Foundation
  7. SBIR Phase I: Handheld Device for Detection of Otitis Media

    SBC: Cactus Medical, LLC            Topic: BM

    This SBIR Phase I project advances a novel medical optical spectroscopy device to facilitate accurate diagnosis of middle ear infections. The device uses a custom multi-LED microchip and photodetectors to illuminate the middle ear and collect reflected light in a familiar otoscope form-factor. Reflected light signatures are analyzed to determine the presence or absence of middle ear fluid - a hall ...

    SBIR Phase I 2019 National Science Foundation
  8. SBIR Phase I: Developing serial suspended microchannel resonators as a platform for personalized medicine in cancer

    SBC: Travera LLC            Topic: BM

    This SBIR Phase I project aims to demonstrate the technical feasibility of a microfluidic instrument as a clinical tool for measuring a new single-cell biophysical biomarker; mass accumulation rate (MAR). Successful completion of the proposed project will constitute the foundation of a medical instrument that will improve treatment strategies for cancer patients. Assigning the optimal therapy for ...

    SBIR Phase I 2019 National Science Foundation
  9. SBIR Phase I: Feasibility of a Wearable Blindness Prevention System

    SBC: Globe Biomedical LLC            Topic: MD

    This Small Business Innovation Research Phase I project comprises the development of a wearable system capable of accurately tracking glaucoma progression via continuous monitoring of intraocular pressure (IOP). Glaucoma is the leading cause of irreversible blindness in the world and affects nearly 80 million people worldwide. Using a novel wearable system, optometrists, ophthalmologists, and medi ...

    SBIR Phase I 2019 National Science Foundation
  10. SBIR Phase I: Bioengineered Recombinant Anticoagulant Heparin

    SBC: TEGA Therapeutics Inc            Topic: BT

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project will be to develop an alternative source of pharmaceutical heparin using engineered cultured mammalian cells. Heparin is a widely prescribed anticoagulant (blood thinner), critical for surgical operations and for patients that otherwise have risks of blood clotting. Over 300,000 doses are admi ...

    SBIR Phase I 2019 National Science Foundation

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government